Publications

Journal Article Scoping Review Epublish 55 citations

PubMed: 35888154 DOI: 10.3390/life12071066

COVID-19 Vaccine and Long COVID: A Scoping Review.

Life (Basel) 12(7)

Authors: Aqsa Mumtaz, Abdul Ahad Ehsan Sheikh, Amin Moazzam Khan, Subaina Naeem Khalid, Jehanzaeb Khan, Adeel Nasrullah, Shazib Sagheer, Abu Baker Sheikh

Affiliations

  • Department of Internal Medicine, Montefiore St. Luke's Cornwall Hospital, Newburgh, NY 12550, USA.
  • Department of Internal Medicine, The Wright Center for Graduate Medical Education, Scranton, PA 18505, USA.
  • Department of Internal Medicine, Shifa College of Medicine, Islamabad 46000, Pakistan.
  • Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87102, USA.
  • Division of Pulmonary and Critical Care, Allegheny Health Network, Pittsburgh, PA 15222, USA.
  • Division of Cardiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87102, USA.

Abstract

As the COVID-19 pandemic progresses, changing definitions and therapeutics regarding the post-acute sequela of COVID-19, particularly long COVID, have become a subject of great interest and study. The study aims to describe the pathophysiology and discuss different therapeutic agents currently available for long COVID. Another objective is to assess comparative efficacy between different types of vaccines on symptoms of long COVID. A preliminary search was conducted using Ovid Medline, Embase, medRxiv, and NIH COVID-19 portfolios. A total of 16 studies were included in our review. Despite some of the data showing variable results, most of the vaccinated patients reported improvement in long COVID symptoms with no significant difference between various types of vaccines. Further trials are needed to better identify the comparative efficacy of vaccines for long COVID and ascertain other therapeutic modalities.

MeSH

Vaccines, Covid-19 Vaccines, Signs And Symptoms, Covid-19, Therapeutics, Post-Acute Covid-19 Syndrome

Cited by